Drug facts

What is “Ozempic face”?

By David Chen·Editor·Reviewed September 2026

What people mean by it⁶

The phrase describes cheeks that look flatter, deeper lines around the nose and mouth, and looser skin along the jaw and neck. In a 2026 survey of 406 dermatologists, plastic surgeons and other clinicians who treat cosmetic patients, midface volume loss and face and neck skin laxity were the changes they most associated with GLP-1 weight loss. That survey reflects what clinicians see in their offices, not a measured rate, and one of its authors is affiliated with Allergan Aesthetics, an aesthetics company.

Is it in the label?¹³

No. The word “facial” does not appear in Wegovy’s label, and no trial in it measured facial appearance. The label does report something relevant, though. It says semaglutide lowers body weight with greater loss of fat mass than lean mass, and the face, like the rest of the body, carries fat that can shrink.

How much weight people lose³

In the largest of Wegovy’s weight-loss trials, about 1,960 adults without diabetes, starting at an average of roughly 105 kg, lost 14.9% of their body weight on semaglutide 2.4 mg over 68 weeks, against 2.4% on placebo. That is an average, so some people lost more and some less. Everyone in the trial was also coached on diet and activity. For more on how the trials were run, see STEP 1.

What scans of the face show⁵

A 2025 study from an academic medical center found 20 patients on GLP-1 drugs who happened to have CT or MRI scans of the head both before and after starting treatment. They had been on the drugs for about 321 days on average and lost about 11 kg. Across the group:

• Total midface volume fell by a median of 9%.
• The superficial fat pads, just under the skin, fell by 11%; the deeper ones by 7%, with wide variation.
• Superficial volume loss tracked weight loss; deep volume loss did not.
• On average, about 7% of midface volume went with every 10 kg of weight lost.

The authors describe this as one of the first measurements of the effect. It is also small, retrospective and not limited to semaglutide, so it shows the direction and rough size of the change, not what will happen to any one face. Because the loss scaled with weight, the fair reading is that the face is following the rest of the body, not that the drug targets it.

Why Ozempic got the name²

Ozempic is approved for type 2 diabetes, not for weight loss. The weight-loss brand of semaglutide is Wegovy. The nickname uses the diabetes brand’s name anyway, and people now apply it to the whole drug class. Nothing in either label suggests Ozempic affects the face differently from Wegovy; the molecule is the same.

When a face change is urgent⁴

Gradual thinning is cosmetic. Sudden swelling is not. The Medication Guide lists swelling of the face, lips, tongue or throat as a sign of a serious allergic reaction, along with trouble breathing or swallowing, a severe rash or itching, a very fast heartbeat, and fainting or dizziness. It says to stop the drug and get medical help right away.

If the change you are seeing is gradual and it bothers you, a dermatologist can explain the options, and your prescriber can talk through the pace of your weight loss. Compounded semaglutide has not been studied for facial changes; like the approved products, it carries the same molecule and the same label warnings. Follow your pharmacy label and prescriber on dosing, and see side effects for everything the label does count.